CZD

CALZADA LIMITED - Announcements

3.13%

9.3¢

Currently unlisted.

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

CZD	Change of Company Name		28/11/14	60.73KB	Share
CZD	Calzada to Divest Metabolic	PRICE SENSITIVE	21/11/14	60.65KB	Share
CZD	Change of Director's Interest Notice		20/11/14	74.3KB	Share
CZD	Change of Director's Interest Notice		20/11/14	73.91KB	Share
CZD	Change of Director's Interest Notice		20/11/14	72.98KB	Share
CZD	Change of Director's Interest Notice		20/11/14	75.67KB	Share
CZD	Appendix 3B		18/11/14	129.65KB	Share
CZD	Results of Meeting		17/11/14	65.27KB	Share
CZD	Chairmans Address		17/11/14	167.76KB	Share
CZD	Appointment of Chief Executive Officer	PRICE SENSITIVE	13/11/14	68.38KB	Share
CZD	FDA Pre-Submission Meeting		31/10/14	132.06KB	Share
CZD	US Regulatory Update	PRICE SENSITIVE	23/10/14	108.63KB	Share
CZD	Annual Report		16/10/14	5.49MB	Share
CZD	Notice of Annual General Meeting/Proxy Form		16/10/14	1.52MB	Share
CZD	International Society for Burn Injuries Presentation		14/10/14	124.51KB	Share
CZD	TGA Notice		29/09/14	125.08KB	Share
CZD	Change of Director's Interest Notice		17/09/14	212.92KB	Share
CZD	Director Resignation		10/09/14	124.83KB	Share
CZD	Full Year Statutory Accounts	PRICE SENSITIVE	25/08/14	1.12MB	Share
CZD	PolyNovo Market Update		12/08/14	161.99KB	Share
CZD	Financial Result Guidance	PRICE SENSITIVE	06/08/14	122.29KB	Share
CZD	Calzada Update on Metabolic Pharmaceuticals	PRICE SENSITIVE	31/07/14	113.58KB	Share
CZD	PolyNovo Receives CE Mark Approval for NovoPore	PRICE SENSITIVE	21/07/14	97.42KB	Share
CZD	Significant Organisational Structure Initiatives	PRICE SENSITIVE	15/07/14	140.85KB	Share
CZD	Change of Director's Interest Notice		04/07/14	216.65KB	Share
CZD	Appendix 3B		04/07/14	360.66KB	Share
CZD	Results of Meeting		01/07/14	119.28KB	Share
CZD	Burn Clinical Trial Update		05/06/14	140.37KB	Share
CZD	Notice of Extraordinary General Meeting/Proxy Form		29/05/14	429.56KB	Share
CZD	Change of Director's Interest Notice		21/05/14	211.74KB	Share
CZD	Initial Director's Interest Notice		15/05/14	124.73KB	Share
CZD	Initial Director's Interest Notice		15/05/14	124.73KB	Share
CZD	Board Appointments		14/05/14	114.07KB	Share
CZD	Appendix 3B		04/04/14	359.19KB	Share
CZD	Appendix 3B		25/03/14	359.58KB	Share
CZD	Appointment of Mr David Williams as Chairman		13/03/14	126.95KB	Share
CZD	Response to ASX Query	PRICE SENSITIVE	04/03/14	167.15KB	Share
CZD	Initial Director's Interest Notice		03/03/14	125.07KB	Share
CZD	Mr David Williams to join the Calzada Board		28/02/14	38.69KB	Share
CZD	Half Yearly Report and Accounts	PRICE SENSITIVE	24/02/14	560.31KB	Share
CZD	Half Year Financial Result Guidance	PRICE SENSITIVE	13/02/14	137.57KB	Share
CZD	RAH Surgeons Receive Approval to use BTM	PRICE SENSITIVE	04/02/14	200.12KB	Share
CZD	Metabolic Licenses AOD9604	PRICE SENSITIVE	28/01/14	144.93KB	Share
CZD	NovoSorb BTM Burn Trial	PRICE SENSITIVE	23/12/13	55.63KB	Share
CZD	Appendix 3B		04/12/13	359.78KB	Share
CZD	Appendix 3B		26/11/13	359.6KB	Share
CZD	Final Director's Interest Notice		19/11/13	149.12KB	Share
CZD	Initial Director's Interest Notice		19/11/13	124.72KB	Share
CZD	Changes to the Calzada Board		15/11/13	106.76KB	Share
CZD	Results of Meeting		15/11/13	92.48KB	Share
CZD	Chairmans Address		15/11/13	166.28KB	Share
CZD	AGM Presentation		15/11/13	617.73KB	Share
CZD	Appendix 3B		14/11/13	359.74KB	Share
CZD	Appendix 3B		07/11/13	360.19KB	Share
CZD	Appendix 3B		28/10/13	360.69KB	Share
CZD	Appendix 3B		17/10/13	360.57KB	Share
CZD	Annual Report to shareholders		15/10/13	6.09MB	Share
CZD	Notice of Annual General Meeting/Proxy Form		15/10/13	372.85KB	Share
CZD	Successful Clinical Trial Outcomes for NovoSorb BTM	PRICE SENSITIVE	10/10/13	165KB	Share
CZD	Ausbiotech Presentation		19/09/13	1.07MB	Share
CZD	510(k) Regulatory Submission For NovoSorb Wound Dressing		18/09/13	151.72KB	Share
CZD	Response to ASX Price and Volume Query	PRICE SENSITIVE	11/09/13	161.07KB	Share
CZD	Full Year Statutory Accounts	PRICE SENSITIVE	28/08/13	1.48MB	Share
CZD	Change in substantial holding		20/08/13	50.7KB	Share
CZD	Financial Result Guidance	PRICE SENSITIVE	16/08/13	61.92KB	Share
CZD	Appendix 3B		07/08/13	347.24KB	Share
CZD	Response to Media Speculation	PRICE SENSITIVE	29/07/13	124.05KB	Share
CZD	Trading halt and request	PRICE SENSITIVE	29/07/13	150.06KB	Share
CZD	Final Patient Treated in NovoSorb BTM Clinical Trial	PRICE SENSITIVE	26/07/13	119.29KB	Share
CZD	Change of Director's Interest Notice		26/07/13	382.93KB	Share
CZD	Change of Director's Interest Notice		26/07/13	382.68KB	Share
CZD	Appendix 3B		25/07/13	600.49KB	Share
CZD	Closing of Share Purchase Plan		23/07/13	137.77KB	Share
CZD	NovoSorb Hernia Repair Feasibility Agreement	PRICE SENSITIVE	17/07/13	131.49KB	Share
CZD	PolyNovo Partners in the Field of Aesthetic Facial Surgery	PRICE SENSITIVE	09/07/13	209.91KB	Share
CZD	Share Purchase Plan	PRICE SENSITIVE	19/06/13	1.38MB	Share
CZD	Appendix 3B and Section 708A Notice		14/06/13	642.84KB	Share
CZD	Shareholder Update		12/06/13	355.76KB	Share
CZD	Placement and Share Purchase Plan	PRICE SENSITIVE	12/06/13	135.28KB	Share
CZD	Trading Halt	PRICE SENSITIVE	07/06/13	72.34KB	Share
CZD	Investor Overview		06/06/13	686.55KB	Share
CZD	American Burns Association Presentations		26/04/13	121.91KB	Share
CZD	AOD9604 Important Clarifications	PRICE SENSITIVE	26/04/13	182.04KB	Share
CZD	Positive Results from NovoSorb Human Clinical Trial	PRICE SENSITIVE	17/04/13	309.95KB	Share
CZD	Appendix 3B		12/04/13	394.41KB	Share
CZD	Topical Negative Pressure Human Trial Completed	PRICE SENSITIVE	28/03/13	121.98KB	Share
CZD	Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/13	875.54KB	Share
CZD	US BARDA Contract Application and BTM Trial Update	PRICE SENSITIVE	18/02/13	331.87KB	Share
CZD	Half Year Financial Result Guidance	PRICE SENSITIVE	15/02/13	123.33KB	Share
CZD	AOD9604 Positive in Osteoarthritis Animal Model	PRICE SENSITIVE	05/02/13	193.85KB	Share
CZD	PolyNovo Concludes Recruitment for VAC Trial	PRICE SENSITIVE	04/02/13	166.47KB	Share
CZD	R and D Tax Refund Received	PRICE SENSITIVE	30/01/13	106.88KB	Share
CZD	Change of Director's Interest Notice		02/01/13	378.05KB	Share
CZD	Change in substantial holding		03/12/12	217.14KB	Share
CZD	Change of Director's Interest Notice		21/11/12	381.34KB	Share
CZD	Change of Director's Interest Notice		21/11/12	382.62KB	Share
CZD	Change of Directors Interest Notice		21/11/12	380.36KB	Share
CZD	Appendix 3B		21/11/12	394.72KB	Share
CZD	Final Director's Interest Notice		15/11/12	97.74KB	Share
CZD	Results of Meeting		14/11/12	145.22KB	Share

CZD Change of Company Name
28/11/14		60.73KB	Share
CZD Calzada to Divest Metabolic
21/11/14	PRICE SENSITIVE	60.65KB	Share
CZD Change of Director's Interest Notice
20/11/14		74.3KB	Share
CZD Change of Director's Interest Notice
20/11/14		73.91KB	Share
CZD Change of Director's Interest Notice
20/11/14		72.98KB	Share
CZD Change of Director's Interest Notice
20/11/14		75.67KB	Share
CZD Appendix 3B
18/11/14		129.65KB	Share
CZD Results of Meeting
17/11/14		65.27KB	Share
CZD Chairmans Address
17/11/14		167.76KB	Share
CZD Appointment of Chief Executive Officer
13/11/14	PRICE SENSITIVE	68.38KB	Share
CZD FDA Pre-Submission Meeting
31/10/14		132.06KB	Share
CZD US Regulatory Update
23/10/14	PRICE SENSITIVE	108.63KB	Share
CZD Annual Report
16/10/14		5.49MB	Share
CZD Notice of Annual General Meeting/Proxy Form
16/10/14		1.52MB	Share
CZD International Society for Burn Injuries Presentation
14/10/14		124.51KB	Share
CZD TGA Notice
29/09/14		125.08KB	Share
CZD Change of Director's Interest Notice
17/09/14		212.92KB	Share
CZD Director Resignation
10/09/14		124.83KB	Share
CZD Full Year Statutory Accounts
25/08/14	PRICE SENSITIVE	1.12MB	Share
CZD PolyNovo Market Update
12/08/14		161.99KB	Share
CZD Financial Result Guidance
06/08/14	PRICE SENSITIVE	122.29KB	Share
CZD Calzada Update on Metabolic Pharmaceuticals
31/07/14	PRICE SENSITIVE	113.58KB	Share
CZD PolyNovo Receives CE Mark Approval for NovoPore
21/07/14	PRICE SENSITIVE	97.42KB	Share
CZD Significant Organisational Structure Initiatives
15/07/14	PRICE SENSITIVE	140.85KB	Share
CZD Change of Director's Interest Notice
04/07/14		216.65KB	Share
CZD Appendix 3B
04/07/14		360.66KB	Share
CZD Results of Meeting
01/07/14		119.28KB	Share
CZDBurn Clinical Trial Update
05/06/14		140.37KB	Share
CZDNotice of Extraordinary General Meeting/Proxy Form
29/05/14		429.56KB	Share
CZDChange of Director's Interest Notice
21/05/14		211.74KB	Share
CZDInitial Director's Interest Notice
15/05/14		124.73KB	Share
CZDInitial Director's Interest Notice
15/05/14		124.73KB	Share
CZDBoard Appointments
14/05/14		114.07KB	Share
CZDAppendix 3B
04/04/14		359.19KB	Share
CZDAppendix 3B
25/03/14		359.58KB	Share
CZDAppointment of Mr David Williams as Chairman
13/03/14		126.95KB	Share
CZDResponse to ASX Query
04/03/14	PRICE SENSITIVE	167.15KB	Share
CZDInitial Director's Interest Notice
03/03/14		125.07KB	Share
CZDMr David Williams to join the Calzada Board
28/02/14		38.69KB	Share
CZDHalf Yearly Report and Accounts
24/02/14	PRICE SENSITIVE	560.31KB	Share
CZDHalf Year Financial Result Guidance
13/02/14	PRICE SENSITIVE	137.57KB	Share
CZDRAH Surgeons Receive Approval to use BTM
04/02/14	PRICE SENSITIVE	200.12KB	Share
CZDMetabolic Licenses AOD9604
28/01/14	PRICE SENSITIVE	144.93KB	Share
CZDNovoSorb BTM Burn Trial
23/12/13	PRICE SENSITIVE	55.63KB	Share
CZDAppendix 3B
04/12/13		359.78KB	Share
CZDAppendix 3B
26/11/13		359.6KB	Share
CZDFinal Director's Interest Notice
19/11/13		149.12KB	Share
CZDInitial Director's Interest Notice
19/11/13		124.72KB	Share
CZDChanges to the Calzada Board
15/11/13		106.76KB	Share
CZDResults of Meeting
15/11/13		92.48KB	Share
CZDChairmans Address
15/11/13		166.28KB	Share
CZDAGM Presentation
15/11/13		617.73KB	Share
CZDAppendix 3B
14/11/13		359.74KB	Share
CZDAppendix 3B
07/11/13		360.19KB	Share
CZDAppendix 3B
28/10/13		360.69KB	Share
CZDAppendix 3B
17/10/13		360.57KB	Share
CZDAnnual Report to shareholders
15/10/13		6.09MB	Share
CZDNotice of Annual General Meeting/Proxy Form
15/10/13		372.85KB	Share
CZDSuccessful Clinical Trial Outcomes for NovoSorb BTM
10/10/13	PRICE SENSITIVE	165KB	Share
CZDAusbiotech Presentation
19/09/13		1.07MB	Share
CZD510(k) Regulatory Submission For NovoSorb Wound Dressing
18/09/13		151.72KB	Share
CZDResponse to ASX Price and Volume Query
11/09/13	PRICE SENSITIVE	161.07KB	Share
CZDFull Year Statutory Accounts
28/08/13	PRICE SENSITIVE	1.48MB	Share
CZDChange in substantial holding
20/08/13		50.7KB	Share
CZDFinancial Result Guidance
16/08/13	PRICE SENSITIVE	61.92KB	Share
CZDAppendix 3B
07/08/13		347.24KB	Share
CZDResponse to Media Speculation
29/07/13	PRICE SENSITIVE	124.05KB	Share
CZDTrading halt and request
29/07/13	PRICE SENSITIVE	150.06KB	Share
CZDFinal Patient Treated in NovoSorb BTM Clinical Trial
26/07/13	PRICE SENSITIVE	119.29KB	Share
CZDChange of Director's Interest Notice
26/07/13		382.93KB	Share
CZDChange of Director's Interest Notice
26/07/13		382.68KB	Share
CZDAppendix 3B
25/07/13		600.49KB	Share
CZDClosing of Share Purchase Plan
23/07/13		137.77KB	Share
CZDNovoSorb Hernia Repair Feasibility Agreement
17/07/13	PRICE SENSITIVE	131.49KB	Share
CZDPolyNovo Partners in the Field of Aesthetic Facial Surgery
09/07/13	PRICE SENSITIVE	209.91KB	Share
CZDShare Purchase Plan
19/06/13	PRICE SENSITIVE	1.38MB	Share
CZDAppendix 3B and Section 708A Notice
14/06/13		642.84KB	Share
CZDShareholder Update
12/06/13		355.76KB	Share
CZDPlacement and Share Purchase Plan
12/06/13	PRICE SENSITIVE	135.28KB	Share
CZDTrading Halt
07/06/13	PRICE SENSITIVE	72.34KB	Share
CZDInvestor Overview
06/06/13		686.55KB	Share
CZDAmerican Burns Association Presentations
26/04/13		121.91KB	Share
CZDAOD9604 Important Clarifications
26/04/13	PRICE SENSITIVE	182.04KB	Share
CZDPositive Results from NovoSorb Human Clinical Trial
17/04/13	PRICE SENSITIVE	309.95KB	Share
CZDAppendix 3B
12/04/13		394.41KB	Share
CZDTopical Negative Pressure Human Trial Completed
28/03/13	PRICE SENSITIVE	121.98KB	Share
CZDHalf Yearly Report and Accounts
25/02/13	PRICE SENSITIVE	875.54KB	Share
CZDUS BARDA Contract Application and BTM Trial Update
18/02/13	PRICE SENSITIVE	331.87KB	Share
CZDHalf Year Financial Result Guidance
15/02/13	PRICE SENSITIVE	123.33KB	Share
CZDAOD9604 Positive in Osteoarthritis Animal Model
05/02/13	PRICE SENSITIVE	193.85KB	Share
CZDPolyNovo Concludes Recruitment for VAC Trial
04/02/13	PRICE SENSITIVE	166.47KB	Share
CZDR and D Tax Refund Received
30/01/13	PRICE SENSITIVE	106.88KB	Share
CZDChange of Director's Interest Notice
02/01/13		378.05KB	Share
CZDChange in substantial holding
03/12/12		217.14KB	Share
CZDChange of Director's Interest Notice
21/11/12		381.34KB	Share
CZDChange of Director's Interest Notice
21/11/12		382.62KB	Share
CZDChange of Directors Interest Notice
21/11/12		380.36KB	Share
CZDAppendix 3B
21/11/12		394.72KB	Share
CZDFinal Director's Interest Notice
15/11/12		97.74KB	Share
CZDResults of Meeting
14/11/12		145.22KB	Share

REFRESH

1 2

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

CALZADA LIMITED - Announcements

Corporate Spotlight
Not Yet Available

Announcements

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

Top Stories

CALZADA LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

Top Stories

Corporate Spotlight
Not Yet Available